Mark P. Labrecque
Impact in
-
- Prostate Cancer Treatment and Research
-
- Cancer, Hypoxia, and Metabolism
- Cancer Genomics and Diagnostics
Papers in
-
- Prostate Cancer Treatment and Research 11
- Lung Cancer Treatments and Mutations 1
-
- Cancer, Hypoxia, and Metabolism 3
- Co-authors
- Timothy V. Beischlag (9 shared papers)Gratien G. Préfontaine (5 shared papers)Peter Nelson (7 shared papers)Ilsa Coleman (7 shared papers)Colm M. Morrissey (6 shared papers)Mandeep Takhar (4 shared papers)Eva Corey (6 shared papers)Brett D. Hollingshead (2 shared papers)
- Journals
- PLoS ONE (4 papers)Clinical Cancer Research (2 papers)Chemico-Biological Interactions (1 paper)Journal of Clinical Investigation (1 paper)Nature Medicine (1 paper)
- Partner nations
- United StatesCanadaGermany
In The Last Decade
Mark P. Labrecque
19 papers receiving 825 citations
Mark P. Labrecque's Hit Papers
Peers
Comparison fields: 5 of 60
- Pulmonary and Respiratory Medicine 508
- Cancer Research 60
- Health, Toxicology and Mutagenesis 53
- Oncology 58
- Geriatrics and Gerontology 9
Countries citing papers authored by Mark P. Labrecque
This map shows the geographic impact of Mark P. Labrecque's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark P. Labrecque with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark P. Labrecque more than expected).
Fields of papers citing papers by Mark P. Labrecque
This network shows the impact of papers produced by Mark P. Labrecque. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark P. Labrecque. The network helps show where Mark P. Labrecque may publish in the future.
Co-authors
The 25 scholars most cited alongside Mark P. Labrecque, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | Molecular profiling stratifies diverse phenotypes of treatment-refractory metastatic castration-resistant prostate cancer Hit paper breakdown → | 2019 | 326 |
| 2 | 2020 | 72 | |
| 3 | 2021 | 61 | |
| 4 | 2019 | 46 | |
| 5 | 2012 | 41 | |
| 6 | 2013 | 37 | |
| 7 | 2021 | 35 | |
| 8 | 2010 | 31 | |
| 9 | 2021 | 31 | |
| 10 | 2018 | 30 | |
| 11 | 2016 | 26 | |
| 12 | 2014 | 23 | |
| 13 | 2015 | 23 | |
| 14 | 2023 | 13 | |
| 15 | 2017 | 11 | |
| 16 | 2023 | 10 | |
| 17 | 2021 | 9 | |
| 18 | 2014 | 8 | |
| 19 | 2026 | 1 | |
| 20 | 2026 | 0 |
About Mark P. Labrecque
Mark P. Labrecque is a scholar working on Pulmonary and Respiratory Medicine, Cancer Research, Health, Toxicology and Mutagenesis, Genetics and Geriatrics and Gerontology, having authored 20 papers that have together received 834 indexed citations. Recurring topics across this work include Prostate Cancer Treatment and Research (11 papers), Cancer, Hypoxia, and Metabolism (3 papers), Genomics and Chromatin Dynamics (2 papers), Estrogen and related hormone effects (2 papers), Epigenetics and DNA Methylation (1 paper), Lung Cancer Treatments and Mutations (1 paper), Cancer Immunotherapy and Biomarkers (1 paper) and Circadian rhythm and melatonin (1 paper). The work is most often cited by research in Pulmonary and Respiratory Medicine (508 citations), Cancer Research (60 citations), Health, Toxicology and Mutagenesis (53 citations), Oncology (58 citations) and Geriatrics and Gerontology (9 citations). Mark P. Labrecque has collaborated with scholars based in United States, Canada and Germany. Frequent co-authors include Timothy V. Beischlag, Gratien G. Préfontaine, Peter Nelson, Ilsa Coleman, Colm M. Morrissey, Mandeep Takhar, Eva Corey, Brett D. Hollingshead, Gary H. Perdew and Joshi J. Alumkal. Their work appears in journals such as PLoS ONE, Clinical Cancer Research, Chemico-Biological Interactions, Journal of Clinical Investigation and Nature Medicine.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.